Exclusive look at our Italian contribution to The Life Sciences Law Review

The fourth edition of The Life Sciences Review was recently published which included valued contributions made by our IP and Life Sciences group in Italy.

Our chapter provides an overview of legal issues of interest to pharmaceutical, biotechnology and medical device companies in the Italian market. It contains information on legal requirements relating to the key stages in the life cycle of a regulated product, from discovery, through the clinical development process, registration, manufacturing and promotion, plus other issues of special interest, such as pricing and reimbursement, special liability regimes, competition and commercial transactions in the context of the medical products business.

The resulting work product will assist industry lawyers, regulatory affairs staff and others who need to have an understanding of the issues in each major market.

Please click here for the PDF version of the exclusive Italy chapter. If you would like to view the eBook or PDF version of the entire Life Sciences Law Review, please click on the image.

News & Deals

More News & Deals
News Bird & Bird Advises Ratiopharm in Landmark Xarelto Patent Revocation Case

Aug 01 2025

Read More
Deal Bird & Bird advises Everystate on its seed funding round

Jul 30 2025

Read More
Deal Bird & Bird advises Marylebone Cricket Club on landmark London Spirit stake transfer

Jul 30 2025

Read More
Deal Bird & Bird advises Bpifrance's SPI 2 fund on Khimod's €23 million fundraising

Jul 29 2025

Read More
News Bird & Bird hires Restructuring & Insolvency team in Singapore

Jul 28 2025

Read More
Deal Bird & Bird advises Akiem on the acquisition, financing and leasing of a fleet of 14 battery-powered electric trains

Jul 22 2025

Read More

Related capabilities